A Clinical Trial To Evaluate Reduning Injection in the Treatment of Mild Type of Hand, Foot, and Mouth Disease
Sponsor: Beijing University of Chinese Medicine
Listed as NCT01175915, this NA trial focuses on Hand, Foot and Mouth Disease and remains ongoing. Sponsored by Beijing University of Chinese Medicine, it has been updated 5 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
5 versions recorded-
Jan 2026 — Present [monthly]
Unknown NA
-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status NA
-
Jan 2017 — Jan 2021 [monthly]
Unknown Status NA
First recorded
May 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Beijing University of Chinese Medicine
- Jiangsu Kanion Pharmaceutical Co., Ltd
For direct contact, visit the study record on ClinicalTrials.gov .